Skip to main content
. 2023 Dec 28;64(5):692–703. doi: 10.60787/NMJ-64-5-292

Table 1.

Baseline characteristics of patients with AKI and without AKI

Baseline characteristics Patients with AKI (n=70) Patients without AKI (n=50) p-value
Median Age (Years) 55 (48±65) 62 (53±68) 0.033
Sex
Male 45 (64.2) 38 (76.0)
Female 25 (35.7) 12 (24.0)
Type of admission
Surgical 30 (42.8) 20 (40.0) 0.368
Medical 40 (57.1) 30 ( 60.0) 0.363
Risk factors for AKI
Preadmission eGFR (ml/min2) 70 (64-80) 95(70-100) <0.001
Sepsis 45 (64.2) 15 (30.0) <0.001
Hypertension 15 (21.4) 10 (20.0) 0.597
Diabetes 10 (14.2) 25(50.0) 0.845
ICU severity score
SOFA score at admission 9.5 (6.1±13.1) 6.3 (4.2±8.6) <0.001
APACHE II score 28 (17-39) 18 (16-24) <0.001
Organ function at admission
Mean arterial pressure (mmHg) 70 (64-84) 74 (65- 85) 0.658
Systolic blood pressure (mmHg) 108 (98-122) 110 (92-126) 0.816
Diastolic blood pressure (mmHg) 58 (52-65) 60 (52- 66) 0.853
Heart rate (beats/min) 80 (60-98) 75 (65- 80) 0.345
Mechanical ventilation 65 (92.8) 44(88.0) 0.099
Serum urea (mg/dl) 50 ±10.71 40±8.37 0.268
Serum creatinine (mg/dl) 1.00 ±0.37 1.0±0.89 0.531
Serum cystatin C (mcg/ml) 14.07 ±4.80 4.28±3.27 <0.001
eGFR cystatin C (mL/min/1.73m2) 3.60± 4.64 30.54±17.00 <0.001
RRI 0.68±0.08 0.55±0.06 0.189
Urine microalbumin (UACR) (mg/dl) 4.25 (1.11-10.30) 2.65 (1.70-3.82) <0.001
Urinary sodium in mmol/24hr 20 (18-70) 92 (46-116) <0.001
Treatment at admission
Vaso pressure 40 (57.1) 21(42) 0.015
Patients receiving nephrotoxic drugs 12 (17.1) 8(16) 0.812
Outcome
Length of stay (days) 6 (3-16) 2 (2-4) <0.001